ImmunityBio Investors Face May 26, 2026, Filing Deadline in Securities Fraud Class Action

Investors in ImmunityBio, Inc. are reminded of the May 26, 2026, filing deadline for a securities fraud class action lawsuit against the company.

11 Apr, 16:35 — 11 Apr, 16:35

Post Share

Sources

Showing 1 of 1 sources

globe-and-mailHigh128d ago

ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP - The Globe and Mail

ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP The Globe and Mail

Read full article →

PERSPECTA

PERSPECTA

ImmunityBio Investors Face May 26, 2026, Filing Deadline in Securities Fraud Class Action

Sources

ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP - The Globe and Mail

Related Stories

Bulgaria Returns 11.6 Tons of Peppers to North Macedonia Due to Pesticides

Goldman Sachs to Acquire ETF Provider Neos in $2.3 Billion Deal

L3Harris CEO Chris Kubasik Ousted Over Unspecified Conduct

KBR Secures $60 Million NATO Contract for Missile Defense System

PERSPECTA